Work

Abstract NT-096: FABCLAVINE, A SECONDARY METABOLITE FROM XENORHABDUS BUDAPESTENSIS AS THERAPY AGAINST OVARIAN CANCER

Year: 2019

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.ovcasymp18-nt-096

Authors: Arvinder K Kapur, Mayur Kajla, Susan Paskewitz, Pooja Mehta, Geeta Mehta, Manish S Patankar

Institution: University of Wisconsin–Madison

Language: English

Topic: Microbial Natural Products and Biosynthesis

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3166823328

Cites:

Cited by: 1

Related to: 10